Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Fluvoxamine

Known as: 1-Pentanone, 5-methoxy-1-(4-(trifluoromethyl)phenyl)-, O-(2-aminoethyl)oxime, (E)-, Fluvoxamina, Fluvoxaminum 
A 2-aminoethyl oxime ether of aralkylketones, with antidepressant, antiobsessive-compulsive, and anxiolytic properties. Fluvoxamine, chemically… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
BACKGROUND Conventional meta-analyses have shown inconsistent results for efficacy of second-generation antidepressants. We… Expand
  • figure 1
  • table 2
  • figure 2
  • table 3
  • figure 3
Highly Cited
2001
Highly Cited
2001
BACKGROUND Drugs that selectively inhibit serotonin reuptake are effective treatments for adults with mood and anxiety disorders… Expand
Highly Cited
2001
Highly Cited
2001
OBJECTIVE To determine the safety and efficacy of fluvoxamine for the treatment of children and adolescents with obsessive… Expand
Highly Cited
2000
Highly Cited
2000
BACKGROUND The study assessed the efficacy and tolerability of the selective serotonin reuptake inhibitor (SSRI) fluvoxamine in… Expand
Highly Cited
1998
Highly Cited
1998
We recently reported that fluoxetine or paroxetine, two selective serotonin reuptake inhibitors (SSRIs), when administered to… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 4
  • figure 3
Highly Cited
1998
Highly Cited
1998
Depression with psychotic features has been shown to respond to selective serotonin reuptake inhibitors (SSRIs). The serotonin… Expand
  • table 1
  • figure 1
Review
1997
Review
1997
The authors analyzed the incidence of sexual dysfunction (SD) with different selective serotonin reuptake inhibitors (SSRIs… Expand
Highly Cited
1996
Highly Cited
1996
Objectives: The purpose of this pharmacokinetic study was to investigate the dose-dependent inhibition of model substrates for… Expand
  • figure 1
  • figure 2
  • figure 3
Highly Cited
1994
Highly Cited
1994
BACKGROUND To determine the efficacy of adding haloperidol to the treatment of patients with obsessive-compulsive disorder (OCD… Expand
Highly Cited
1989
Highly Cited
1989
The development design and reliability of the Yale-Brown Obsessive Compulsive Scale have been described elsewhere. We focused on… Expand